Background: Research shows that prostate cancer ranks second among the top five most
common cancers in men. It has been confirmed that if the circulating Prostate Specific …

Prostate cancer is the second common form of cancer in men. Detection of circulating
Prostate Specific Antigen (PSA) transcripts has effectively been used for early diagnosis of …

Objectives. To develop a rapid, sensitive, reverse transcriptase-polymerase chain reaction
(RT-PCR) prostate-specific antigen (PSA) messenger ribonucleic acid (mRNA) detection …

PURPOSE: Polymerase chain reaction is a powerful tool for expanding minute quantities of
deoxyribonucleic acid (DNA) for detailed study. Reverse transcriptase polymerase chain …

Prostate cancer is the second common form of cancer in men. Detection of circulating
Prostate Specific Antigen [PSA] transcripts has effectively been used for early diagnosis of …

OBJECTIVE: To determine accurately the conditions for the development of tests using RT-
PCR for PSA in patients with prostate cancer. METHOD: Gen amplification of PSA in cultures …

We have developed a time-resolved fluorometric hybridization assay for detecting prostate-
specific antigen (PSA) mRNA amplified by reverse transcription polymerase chain reaction …

Purpose: There have been several studies on the presence of circulating tumor cells in the
peripheral blood of patients with malignant tumors including prostate cancer (PCa) using …

Circulating prostate cells can be detected in peripheral blood of patients with clinically
localized or advanced prostate carcinoma. Traditionally, nested reverse transcriptase …

In recent years, the mRNA for prostate-specific antigen (PSA) has been investigated as a
potential marker for molecular staging of prostate cancer. We report a simple, rapid, and …